Skin tissue cholesterol is not related to vascular occlusive disease

Abstract

The objective of the present study was to evaluate the role of skin tissue cholesterol (SkinTc) in predicting the presence of atherosclerosis. SkinTc concentrations were determined in 318 consecutive patients by using the non-invasive PREVU POC Skin Sterol Test. Additionally, a complete lipid status and cardiovascular risk profile according to the PROCAM and Framingham scores as well as an evaluation by carotid duplex sonography and ankle—brachial blood pressure index testing was obtained from all patients. SkinTc concentrations did not differ significantly among patients suffering from cerebrovascular disease (CVD) and peripheral arterial disease (PAD) compared to the corresponding control groups and among patients with a calculated cardiovascular risk > 10% in 10 years compared to patients with a risk< 10% (all p > 0.05). Additionally, SkinTc concentrations were not significantly higher in the 245 patients with at least one documented atherosclerotic disease compared with the remaining 73 patients without evidence of atherosclerosis. In conclusion, SkinTc concentrations determined by the PREVU POC Skin Sterol Test are not related to the presence of CVD and PAD or to an elevated cardiovascular risk, indicating that this parameter cannot be used as a reliable indicator of atherosclerosis.

Keywords

atherosclerosis cholesterol Framingham PREVU POC Skin Sterol Test PROCAM skin tissue cholesterol

References

Grundy SM , Balady GJ , Criqui MH et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998; 97: 1876—87.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143—421.

Prabhakaran D. , Anand SS The metabolic syndrome: an emerging risk state for cardiovascular disease. Vasc Med 2004; 9: 55—68.

MacMahon S. , Sharpe N. , Gamble G. et al. Effects of lowering average and below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. Circulation 1998; 97: 1784—90.

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7—22.

Ridker PM C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003; 108: 81—85.

De Graeve J , Bouissou H. , Thiers JC , Fouet J. , Valdiguie P.

Is cutaneous apoprotein B a better discriminator than serum lipoproteins for atherosclerosis?

Atherosclerosis 1984; 52: 301—307.

Bouissou H. , de Graeve J. , Legendre C. , Solera ML , Wulfert E. , Thiers JC Skin cholesterol and skin apoprotein B in atherosclerosis. Biomed Pharmacother 1982; 36: 159—62.

Bouissou H. , De Graeve J , Solera ML et al. Cutaneous cholesterol in the young and aged coronary patient . Arch Mal Coeur Vaiss 1982; 75: 621—26.

10.

Zawydiwski R. , Sprecher DL , Evelegh MJ , Horsewood P. , Carte C. , Patterson M. A novel test for the measurement of skin cholesterol . Clin Chem 2001; 47: 1302—304.

11.

Mancini GB , Chan S. , Frohlich J. , Kuramoto L. , Schulzer M. , Abbott D. Association of skin cholesterol content, measured by a non-invasive method, with markers of inflammation and Framingham risk prediction. Am J Cardiol 2002; 89: 1313—16.

12.

Sprecher DL , Goodman SG , Kannampuzha P. , Pearce GL , Langer A. Skin tissue cholesterol (SkinT(c)) is related to angiographically-defined cardiovascular disease. Atherosclerosis 2003; 171: 255—58.

13.

Vaidya D. , Ding J. , Hill JG et al. Skin tissue cholesterol assay correlates with presence of coronary calcium. Atherosclerosis 2005; 181: 167—73.

14.

Sprecher DL , Pearce GL Elevated skin tissue cholesterol levels and myocardial infarction. Atherosclerosis 2005 ; 181: 371—73.

15.

Tzou WS , Mays ME , Korcarz CE , Aeschlimann SE , Stein JH Skin cholesterol content identifies increased carotid intimamedia thickness in asymptomatic adults. Am Heart J 2005; 150: 1135—39.

16.

Reiter M. , Wirth S. , Pourazim A. et al. Skin cholesterol: test performance, evaluation of potential determinants and correlation analysis with cardiovascular risk factors and circulating markers of inflammation. VASA 2006; 35: 167—73.

17.

Reiter M. , Wirth S. , Pourazim A. , Baghestanian M. , Minar E. , Bucek RA Statin therapy has no significant effect on skin tissue cholesterol: results from a prospective randomized trial. Clin Chem 2005; 51: 252—54.

18.

Pearson TA New tools for Coronary Risk Assessment. What are their advantages and limitations ? Circulation 2002; 105: 886—92.

19.

Wilson PW , D'Agostino RB , Levy D. , Belanger AM , Silbershatz H. , Kannel WB Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837—47.

20.

Assmann G. , Cullen P. , Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310—15.

21.

Nicolaides AN , Shifrin EG , Bradbury A. et al. Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion? J Endovasc Surg 1996; 3: 158—65.

22.

Sabeti S. , Schillinger M. , Mlekusch W. et al. Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria. Radiology 2004; 232: 431—39.

23.

Dormandy JA , Rutherford RB Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000; 31: S1—296.

24.

Chobanian AV , Bakris GL , Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560—72.

25.

Anand SS , Razak F. , Vuksan V. et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care 2003; 26: 290—96.

26.

Little RR , Rohlfing CL , Wiedmeyer HM , Myers GL , Sacks DB , Goldstein DE ; NGSP Steering Committee. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001 ; 47: 1985—92.

27.

Stampfer MJ , Hu FB , Manson JE , Rimm EB , Willett WC Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343: 16—22.

28.

Wyman RA , Mays ME , McBride PE , Stein JH Ultrasound-detected carotid plaque as a predictor of cardiovascular events . Vasc Med 2006; 11: 123—30.